Instructions
Please read this page carefully. You will need to scroll down this page and ensure that you have read the learning objectives, accreditation information, and potential conflicts of interest disclosures for the authoring faculty. Please check the box to agree to the terms of understanding and click the "Start Module" button on the bottom of the page to begin your learning activity.

Learning Objectives
After completing this educational activity, the learner should be better able to:

• List the criteria for appropriate selection of patients with stage II colon cancer for adjuvant therapy and also select the most appropriate adjuvant regimens for patients with stage III colon cancer.
• Explain the methods of post-treatment surveillance and decide which types of follow-up screening are appropriate for patients who have completed adjuvant therapy
• Discuss the standards of care for patients with advanced colon cancer, including determining the most effective and appropriate sequences of chemotherapeutic agents and combinations
• Compare and contrast the various first-line regimens currently available for metastatic colon cancer
• Describe the role of targeted agents in advanced colorectal cancer
• Determine an optimal schedule for supportive care in the management of relapsed metastatic disease
• Identify promising new agents in the treatment of colorectal cancer
• Discuss the role of various imaging options and biomarkers in the monitoring of patients with advanced colorectal cancer
• Review the developing criteria for determining patient suitability for resection
• Compare differences in treatments depending on whether the liver metastasis is resectable and understand the complications that may arise as a result of these treatments

Accreditation
This learning activity has expired however you may still review module content.

Target Audience
This learning activity is intended for a broad audience of healthcare practitioners, including medical oncologists, primary care physicians, family physicians, specialists, nurse practitioners, and physician assistants.

Disclosure Statements
To view the Disclosure Statements, please click here.